Is an ApoB Level of 85 mg/dL Acceptable?
An apolipoprotein B level of 85 mg/dL is generally acceptable for most individuals, but whether it's optimal depends entirely on your cardiovascular risk category—for very high-risk patients (established cardiovascular disease, diabetes with additional risk factors), this level exceeds the recommended target of <80 mg/dL and requires treatment intensification.
Risk-Stratified ApoB Targets
The appropriateness of your ApoB level of 85 mg/dL must be evaluated against guideline-recommended targets based on cardiovascular risk stratification:
Very High-Risk Patients
- Target: ApoB <80 mg/dL 1, 2
- Includes patients with:
- Established cardiovascular disease (prior heart attack, stroke, peripheral artery disease)
- Type 2 diabetes with cardiovascular disease or chronic kidney disease
- Type 2 diabetes with ≥1 additional risk factor
- Calculated 10-year cardiovascular risk >20%
- Familial hypercholesterolemia
- Your level of 85 mg/dL exceeds this target and warrants treatment intensification
High-Risk Patients
- Target: ApoB <100 mg/dL 3
- Includes patients with:
- Diabetes without additional risk factors
- Chronic kidney disease stage 3-4 without other risk factors
- 2+ risk factors with 10-20% 10-year cardiovascular risk
- Your level of 85 mg/dL meets this target
Moderate/Lower-Risk Patients
- Target: ApoB <90-100 mg/dL 2, 4
- For individuals with ≤2 risk factors and <10% 10-year cardiovascular risk
- Your level of 85 mg/dL is within acceptable range
Extreme Risk Patients
- Target: ApoB <70 mg/dL 2
- For progressive cardiovascular disease despite achieving LDL-C <70 mg/dL, or established cardiovascular disease with diabetes/chronic kidney disease/familial hypercholesterolemia
- Your level of 85 mg/dL significantly exceeds this target
Key Clinical Context
ApoB is superior to LDL-C for risk assessment, particularly in patients with:
- Hypertriglyceridemia (triglycerides >150 mg/dL) 3, 5
- Metabolic syndrome
- Diabetes
- Small, dense LDL particles
The 2016 ESC/EAS guidelines explicitly state that ApoB "is a better index of the adequacy of LDL-lowering therapy" than LDL-C, with less laboratory error in measurement 3.
Population Reference Data
Recent research provides context for your level:
- Mean ApoB in healthy populations: 94-103 mg/dL 6, 7
- The 50th percentile corresponds to approximately 95-100 mg/dL 6, 7
- Your level of 85 mg/dL falls below the population median, suggesting lower-than-average atherogenic particle burden in general populations
However, population norms are not treatment targets—your goal should be determined by your individual cardiovascular risk profile, not population averages.
Critical Pitfall to Avoid
Do not assume your ApoB is acceptable based solely on the number itself. The most common error is failing to risk-stratify appropriately. A level of 85 mg/dL that's acceptable for a healthy 40-year-old with no risk factors is inadequate for a 60-year-old with diabetes and prior myocardial infarction. The latter patient requires aggressive lipid-lowering therapy (typically high-intensity statin ± ezetimibe) to achieve ApoB <80 mg/dL 1.
Actionable Recommendation
Determine your cardiovascular risk category using established criteria (presence of cardiovascular disease, diabetes, chronic kidney disease, calculated 10-year risk, family history of premature cardiovascular disease). If you fall into the very high-risk or extreme risk categories, your ApoB of 85 mg/dL requires treatment intensification with statins and potentially ezetimibe to reach target levels <80 mg/dL or <70 mg/dL respectively 1, 2.